Artificial Intelligence in Epidemiology Market
完整報告名稱與涵蓋範圍
Artificial Intelligence in Epidemiology Market Size, Share & Trends Analysis Report By Deployment (Web-Based, Cloud-Based), By Application (Infection Prediction and Forecasting, Disease and Syndromic Surveillance), By End-Use, By Region, And by Segment Forecasts, 2025-2034
報告摘要
A CAGR of 27.4% is forecasted for the global Artificial Intelligence in Epidemiology Market over the assessment period of 2025 through 2034.
At its core, Artificial Intelligence in Epidemiology pertains to key industry insights & findings from the report:
Artificial intelligence enables us to efficiently process and analyze large and complex data sets, including electronic health records, genomic data,. Stakeholders across the technology and communications landscape are mountingly turning to these solutions to meet contemporary demands.
The market's upward path is bolstered by mounting healthcare spending, technological evolution, and the mounting focus on personalized and precision-based approaches in technology and communications.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Artificial Intelligence In Epidemiology Market Snapshot
Chapter 4. Global Artificial Intelligence In Epidemiology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Deployment Type Estimates & Trend Analysis
5.1. by Deployment Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Deployment Type:
5.2.1. On-premise
5.2.2. Cloud-based
5.2.3. Web-based
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
6.2.1. Infection Prediction and Forecasting
6.2.2. Disease and Syndromic Surveillance
Chapter 7. Market Segmentation 3: by End-use Estimates & Trend Analysis
7.1. by End-use & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-use:
7.2.1. Government and State Agencies
7.2.2. Research Labs
7.2.3. Pharmaceutical and Biotechnology Companies
7.2.4. Healthcare Providers
Chapter 8. Artificial Intelligence In Epidemiology Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Artificial Intelligence In Epidemiology Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2021-2034
8.1.2. North America Artificial Intelligence In Epidemiology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.1.3. North America Artificial Intelligence In Epidemiology Market revenue (US$ Million) by End-use, 2021-2034
8.1.4. North America Artificial Intelligence In Epidemiology Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Deployment Type, 2021-2034
8.2.2. Europe Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Application, 2021-2034
8.2.3. Europe Artificial Intelligence In Epidemiology Market revenue (US$ Million) by End-use, 2021-2034
8.2.4. Europe Artificial Intelligence In Epidemiology Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Deployment Type, 2021-2034
8.3.2. Asia Pacific Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Application, 2021-2034
8.3.3. Asia-Pacific Artificial Intelligence In Epidemiology Market revenue (US$ Million) by End-use, 2021-2034
8.3.4. Asia Pacific Artificial Intelligence In Epidemiology Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Deployment Type, 2021-2034
8.4.2. Latin America Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Application, 2021-2034
8.4.3. Latin America Artificial Intelligence In Epidemiology Market revenue (US$ Million) by End-use, 2021-2034
8.4.4. Latin America Artificial Intelligence In Epidemiology Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Deployment Type, 2021-2034
8.5.2. Middle East & Africa Artificial Intelligence In Epidemiology Market revenue (US$ Million) by Application, 2021-2034
8.5.3. Middle East & Africa Artificial Intelligence In Epidemiology Market revenue (US$ Million) by End-use, 2021-2034
8.5.4. Middle East & Africa Artificial Intelligence In Epidemiology Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Cognizant Technology Solutions Corporation
9.2.2. Cerner Corporation (Oracle)
9.2.3. Epic Systems Corporation
9.2.4. eClinicalWorks LLC
9.2.5. Alphabet Inc.
9.2.6. Komodo Health
9.2.7. Microsoft Corporation
9.2.8. Meditech
9.2.9. Predixion Software
9.2.10. Siemens Healthineers AG
9.2.11. Intel Corporation
9.2.12. Bayer Healthcare
9.2.13. Artificial Intelligence for Medical Epidemiology (AIME)
9.2.14. Cardiolyse
9.2.15. SAS Institute, Inc.
9.2.16. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們